Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8383
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rauff, Bisma | - |
dc.contributor.author | Ramezani-Moghadam, Mehdi | - |
dc.contributor.author | Tay, Enoch S. | - |
dc.contributor.author | George, Jacob | - |
dc.contributor.author | Douglas, Mark W. | - |
dc.date.accessioned | 2024-01-23T01:00:21Z | - |
dc.date.available | 2024-01-23T01:00:21Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Future Virology 18(12):757-766, 2023 | - |
dc.identifier.uri | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8383 | - |
dc.description.abstract | AIM: To investigate the mechanism of liver fibrosis in chronic hepatitis C virus (HCV) infection we developed an in vitro model. METHODS: Huh7 cells were transfected with HCV (JFH1 or Jc1) or sub-genomic replicons and expression of pro-fibrotic cytokines determined by qPCR. Media from infected cells was transferred onto LX2 cells or primary rat stellate cells and expression of pro-fibrotic genes measured by qPCR. RESULTS: Replication competent HCV, but not sub-genomic replicons, induced expression of TGF-beta1 and CTGF. Supernatant from infected cells induced alpha-SMA and COL1A1 expression and stellate cell migration, confirming functional activation. CONCLUSIONS: Infected cells produce pro-fibrogenic cytokines TGF-beta1 and CTGF and activate stellate cells. This mechanism could be targeted to prevent or treat HCV-induced fibrosis. | - |
dc.subject | Infections | - |
dc.subject | Hepatology | - |
dc.title | Development of an in vitro model to study hepatitis C virus-induced fibrosis | - |
dc.type | Journal Article | - |
dc.identifier.doi | https://dx.doi.org/10.2217/fvl-2022-0206 | - |
dc.subject.keywords | cell migration | - |
dc.subject.keywords | Hepatitis C | - |
dc.identifier.journaltitle | Future Virology | - |
dc.identifier.department | Westmead Institute for Medical Research | - |
dc.identifier.department | Gastroenterology and Hepatology | - |
dc.identifier.department | Pathology | - |
dc.identifier.department | Infectious Diseases | - |
dc.contributor.wslhd | Rauff, Bisma | - |
dc.contributor.wslhd | Ramezani-Moghadam, Mehdi | - |
dc.contributor.wslhd | Tay, Enoch S. | - |
dc.contributor.wslhd | George, Jacob | - |
dc.contributor.wslhd | Douglas, Mark W. | - |
dc.type.studyortrial | Controlled Study | - |
dc.identifier.affiliation | Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia | - |
dc.identifier.affiliation | Centre for Infectious Diseases and Microbiology, Sydney Infectious Diseases Institute, University of Sydney, Westmead Hospital, Westmead, NSW, Australia | - |
dc.identifier.facility | Blacktown | - |
dc.identifier.facility | Westmead | - |
Appears in Collections: | Blacktown Mount Druitt Hospital |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.